Last update 25 Mar 2025

Recombinant anti-CD20 monoclonal antibody(Xinlitai (Genekey Biotech (Chengdu) )

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms-
Target
CD20
Action
inhibitors
Mechanism
CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects), CD20-directed cytolytic effects
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication-
Inactive Indication
LymphomaRheumatoid Arthritis
Originator Organization
Genekey Biotech (Chengdu) Co. Ltd.Genekey Biotech (Chengdu) Co. Ltd.
Active Organization-
Inactive Organization
Genekey Biotech (Chengdu) Co. Ltd.Genekey Biotech (Chengdu) Co. Ltd.Tianjin Bogene Technology Co Ltd
Drug Highest PhasePendingIND Application
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Recombinant anti-CD20 monoclonal antibody(Xinlitai (Genekey Biotech (Chengdu) )
Login to view more data
100 Translational Medicine associated with Recombinant anti-CD20 monoclonal antibody(Xinlitai (Genekey Biotech (Chengdu) )
Login to view more data
100 Patents (Medical) associated with Recombinant anti-CD20 monoclonal antibody(Xinlitai (Genekey Biotech (Chengdu) )
Login to view more data
100 Deals associated with Recombinant anti-CD20 monoclonal antibody(Xinlitai (Genekey Biotech (Chengdu) )
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
LymphomaIND Application
China
Genekey Biotech (Chengdu) Co. Ltd.Genekey Biotech (Chengdu) Co. Ltd.
27 Dec 2013
LymphomaIND Application
China
Tianjin Bogene Technology Co Ltd
27 Dec 2013
Rheumatoid ArthritisIND Application
China
Genekey Biotech (Chengdu) Co. Ltd.Genekey Biotech (Chengdu) Co. Ltd.
27 Dec 2013
Rheumatoid ArthritisIND Application
China
Tianjin Bogene Technology Co Ltd
27 Dec 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free